Not All Coronary Spasms Are the Same: Benefits of Acetylcholine

Patients with documented spasm to the coronary arteries present increased risk of myocardial infarction (MI) and repeat angiography, while patients with microvascular spasm are associated to recurrent angina. 

¿FFR de rutina en pacientes con síndrome coronario agudo?

Globally, the prognosis of all these patients continues to be favourable, even though acetylcholine testing might help distinguish one-another. 

Coronary spasm shows in up to 60% of patients with myocardial ischemia symptoms despite not presenting obstructive coronary lesions. 

This recent study published in JACC Interv retrospectively included consecutive patients with no obstructive coronary lesions undergoing acetylcholine testing for epicardial or microvascular spasm detection. 

Mortality, non-fatal MI, stroke, repeat angiography, recurrent symptoms, and quality of life of 736 patients were registered and followed up for 7.2 years.


Read also: IN.PACT AV ACCESS | Drug-Coated Balloons for Dialysis Fistulas.


Mortality in this followup period was 7.5%, non-fatal MI rate was 1.4%, and stroke reached 2.2%. 

Most patients reported recurrent angina (64%). This motivated repeat angiography (12%) which, same as before, showed no obstructive lesions.

Epicardial spasm was a predictor of non-fatal MI (HR: 14.4) and repeat angiography (HR: 1.7), while microvascular spasm predicted more symptoms (HR: 1.3).

Conclusion

The general prognosis of patients with coronary spasm is favourable. Acetylcholine testing helped identify patients with epicardial MI, with higher risk of non-fatal MI and repeat angiographies vs. patients with microvascular spasm associated to higher risk of recurrent angina. 

Original Title: Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing.

Reference: Andreas Seitz et al. JACC Cardiovasc Interv. 2020 Aug 24;13(16):1865-1876. https://doi.org/10.1016/j.jcin.2020.05.009.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

AHA 2024 | SUMMIT

It has been previously shown that the pharmacological treatment of obesity (semaglutide) can reduce cardiovascular events in patients with cardiac failure (CF) and preserved...

AHA 2024 – BPROAD

Hypertension (elevated blood pressure, BP) is the most common comorbidity among diabetic patients and has been associated with higher cardiovascular risk, though as a...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...